Inspire Medical Systems, Inc. Profile Avatar - Palmy Investing

Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Ins…
Medical - Devices
US, Golden Valley [HQ]

Cash Flow Statements

9 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-22.00 -17.00 -15.00 -18.00 -32.00 -53.00 -20.00 11.00 24.00
Operating Cash (Net)
-22.00 -17.00 -15.00 -18.00 -32.00 -53.00 -20.00 11.00 24.00
Accounts Receivable
- - - - -1.00 -2.00 -6.00 -11.00 -9.00 -27.00 -30.00
Accounts Payable
- - - - 1.00 - - 1.00 2.00 4.00 14.00 9.00
Working Capital
- - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
23.00 - - -7.00 -83.00 -43.00 86.00 29.00 -19.00 -294.00
Capital Expenditure
- - - - - - - - -2.00 -2.00 -4.00 -9.00 -23.00
Purchases of Investments
- - - - -8.00 -115.00 -178.00 -52.00 -9.00 -10.00 -281.00
Sale/Maturity of Investment
23.00 - - 1.00 32.00 137.00 141.00 43.00 - - 10.00
Property, Plant, Equipment (P&PE)
- - - - - - - - -2.00 -2.00 -4.00 -9.00 -23.00
Acquisitions (Net)
- - - - - - - - 40.00 -89.00 -33.00 - - 271.00
Other Investing Activities
- - - - - - - - -40.00 89.00 33.00 -10.00 -271.00
Financing Activities
Used Cash (Net)
-2.00 -12.00 -25.00 -190.00 -1.00 -134.00 -14.00 -235.00 -13.00
Debt Repayment
-7.00 - - - - - - - - - - - - -24.00 - -
Dividends Paid
- - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - 11 259 48
Other Financing Activities
9.00 12.00 25.00 8.00 1.00 134.00 -3.00 - - 31.00
Cash Balances
Begin of Period
8.00 12.00 6.00 8.00 97.00 22.00 190.00 214.00 441.00
End of Period
12.00 6.00 8.00 97.00 22.00 190.00 214.00 441.00 185.00
Change
3.00 -5.00 2.00 88.00 -74.00 167.00 23.00 227.00 -256.00
Non-Cash Balances
Depreciation and Amortization
- - - - - - - - - - - - 1.00 1.00 2.00
Stock Based Compensation
- - - - - - - - 6.00 12.00 26.00 51.00 82.00
Other
- - - - - - - - 1.00 1.00 1.00 - - 3.00
Highlighted metrics
Free Cash Flow (FCF)
-22.00 -18.00 -16.00 -18.00 -35.00 -55.00 -24.00 2.00 1.00
Cash Conversion Cycle (CCC)
- - 250.00 90.00 20.00 95.00 105.00 114.00 -27.00 33.00
Invested Capital
- - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of INSP's Analysis
CIK: 1609550 CUSIP: 457730109 ISIN: US4577301090 LEI: - UEI: -
Secondary Listings
INSP has no secondary listings inside our databases.